arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Allarity Therapeutics, Inc.

ALLR

$1.03 ▼ -0.07 (-5.91%) at close

27 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Allarity Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $16.4M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -59.7% ↘

FCF / Share $-0.16 ↗

Trailing P/E —

Price / Book 4.6x

FCF Yield —

Debt / Equity 5.90

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-2.75M

↓ -0.7% —

FCF / Share Free cash flow per share

$-0.16

↑ +43.5% —

Long-Term Debt Long-term obligations

$2.69M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
EPS Growth YoY (%)	-40.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	32.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	N/M	97.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-36.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	98.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-99.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-244.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	99.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-399.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	99.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3550.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-691.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-14366.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	17.6% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-0.7% Weak ↓ Weak Declining Year-over-year change in net income	-0.7% Weak ↓ Weak Declining Year-over-year change in net income	54.7% Excellent ↑ Excellent Improving Year-over-year change in net income	28.9% Excellent ↑ Excellent Improving Year-over-year change in net income	28.9% Excellent ↑ Excellent Improving Year-over-year change in net income	28.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-332.8% Weak ↓ Weak Declining Year-over-year change in net income	-14.6% Weak ↓ Weak Declining Year-over-year change in net income	-14.6% Weak ↓ Weak Declining Year-over-year change in net income	-14.6% Weak ↓ Weak Declining Year-over-year change in net income	39.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-8.8% Weak ↓ Weak Declining Year-over-year change in net income	-8.8% Weak ↓ Weak Declining Year-over-year change in net income	-8.8% Weak ↓ Weak Declining Year-over-year change in net income	83.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	0.2% Caution ↑ Caution Improving Year-over-year change in net income	0.2% Caution Caution Year-over-year change in net income	-518.3% Weak Weak Year-over-year change in net income	N/M	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-18.4% Weak Weak Year-over-year change in free cash flow	—	—	—	97.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-100.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-508.1% Weak Weak Year-over-year change in free cash flow	—	—	—	-22.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Effective Tax Rate (%) (%)	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.66x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.43x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.87x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Return on Invested Capital (%)	-59.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-92.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	65.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	8009.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	505.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	454.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	93.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	4719.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-249.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-98.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-8.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-41.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-20.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-77.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-618%)	-39.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-34.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-22.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-22.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-14.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-63.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	-29.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-298%)	-19.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	59.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+296%)	62.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+317%)	99.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+561%)	—	108.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+620%)	—	-212.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1519%)	-38.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-358%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-92.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-718%)	5.1% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-13.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-11.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-3.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Debt to Equity (x)	5.90x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+883%)	2.90x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+384%)	—	—	—	—	—	—	—	—	-0.98x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-263%)	-0.80x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-233%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	-487.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-41.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2439.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-130.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-58.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-130.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-1408.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-75.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-114.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-24.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-8.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$3.88M	$268.00K	$-14.69M	$-16.89M	$-17.80M	$-25.20M	$-19.53M	—	$-19.23M	$-312.00K	$2.52M	$1.29M	$-420.00K	—	$-2.03M	$-3.95M	—	—	—	$-5.58M	—	—	—	$-30.00K	—	—	$-1.52M
Debt / EBITDA (x)	-7.81x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	-0.55x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.61x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Revenue per Share (USD)	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.21	$-0.17	$-0.21	$-0.19	$-0.15	$-0.25	$9.68	$-7.71	$-0.11	$-22.14	$5.60K	$-2.24	$-26.28	$-4.43	$-360.21	$-934.29	$-0.72	$-0.56	$-2.49	—	$-1.08	$-0.68	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.16	$-0.29	—	$-0.23	—	$-0.24	—	—	—	$-8.48	—	—	—	$-4.22	—	—	—	$-0.69	—	—	$-0.85	$-0.57	—	—	—	—	—
Book Value per Share (USD)	$0.22	$0.44	$0.61	$0.75	$0.83	$1.10	$1.62	$4.70	$0.57	$-18.88	—	$-0.81	$-1.44	$-2.61	—	—	$0.86	$1.67	$2.24	$0.08	$5.82	$5.18	$5.75	$0.13	—	—	—
Tangible Book Value per Share (USD)	$0.22	$0.44	$0.61	$0.75	$0.83	$1.10	$1.62	$4.70	$0.57	$-18.88	—	$-0.81	$-20.72	$-10.78	—	—	$-0.52	$0.12	$-1.23	$0.01	$5.82	$5.18	$-1.42	$0.13	—	—	—
Basic Weighted Avg Shares (shares)	15.91M	15.97M	—	14.74M	15.54M	11.15M	—	1.58M	14.98M	175,266	—	2.47M	372,414	758,144	—	7,153	9.02M	8.29M	—	387.65M	5.02M	4.53M	—	186.23M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Working Capital (USD)	$3.15M	$6.50M	$9.50M	$11.68M	$11.85M	$18.36M	$11.50M	$12.95M	$10.69M	$-15.71M	$-12.20M	$-11.36M	$-8.98M	$-8.62M	$-6.25M	—	$-1.34M	$4.50M	$685.00K	$3.80M	—	—	$-3.82M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	$2.69M	$2.69M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$3.54M	$6.92M	$9.83M	$12.01M	$12.17M	$18.67M	$11.81M	$12.96M	$19.84M	$-6.47M	$-2.75M	$-3.38M	$-723.00K	$-3.10M	$-113.00K	$1.45M	$7.97M	$14.73M	$18.15M	$32.77M	$29.22M	$23.47M	$24.44M	$24.66M	—	—	$20.90M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Dec 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Sales/Revenue/Turnover (USD)	$0.00	$25.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	$12.00K	$11.00K	—	—	—	—	—	—	—	—	—	—	$24.00K	$23.00K	$16.00K	$37.00K	$-3.00K	$56.00K	$-64.00K	$38.00K	—	—	—
Net Income, GAAP (USD)	$-2.75M	$-2.75M	$-3.37M	$-2.73M	$-2.73M	$-2.73M	$-7.45M	$-3.84M	$-3.84M	$-3.84M	$-1.72M	$-3.35M	$-3.35M	$-3.35M	$-2.84M	$-3.08M	$-3.08M	$-3.08M	$-16.82M	$1.67M	$-3.08M	$-3.08M	$-2.72M	$-960.00K	—	—	—
Operating Cash Flow (USD)	$-2.56M	$-4.49M	$-3.24M	$-3.41M	—	$-2.69M	$-3.21M	—	—	$-1.49M	$-1.67M	—	—	$-3.20M	$-2.45M	$-4.41M	—	$-5.75M	$-4.32M	—	$-4.27M	$-2.57M	$-2.44M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Allarity Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALLR with peers